2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
5
Mucositis
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Febrile Neutropenia
2
Cytokine Release Syndrome
2
Burkitt Lymphoma
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Smoldering Multiple Myeloma
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Neurotoxicity Syndromes
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Inflammation
1
Hematologic Neoplasms
1
Early Stage Triple Negative ER Low Breast Cancer
1
Disease Progression
1
Cryopyrin-Associated Periodic Syndromes
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Arthritis, Rheumatoid
1
Interventions
Metformin
152
Clomiphene
52
Letrozole
41
Inositol
35
Folic Acid
18
Progesterone
17
Exercise
17
Ethinyl Estradiol
13
Estradiol
13
Chorionic Gonadotropin
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Contraceptives, Oral
12
cetrorelix
11
Pioglitazone
10
High-Intensity Interval Training
10
Cholecalciferol
10
Triptorelin Pamoate
9
Tablets
9
Spironolactone
9
Menotropins
8
Diet
8
Vitamin D
7
Thioctic Acid
7
Surveys and Questionnaires
7
Liraglutide
7
Gonadotropins
7
Acupuncture Therapy
7
follitropin alfa
6
drospirenone
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycystic Ovary Syndrome
×
Interleukin 1 Receptor Antagonist Protein
×
Clear all
NCT03578497
2021-01-27
FertIL
University Hospital, Basel, Switzerland
Phase 2
Completed
18 enrolled